Which hedge funds own CHE? CHEMED CORP NEW, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in CHE (CHEMED CORP NEW) in their Q2 2026 13F filings, worth $100.1m in total. The largest holder by portfolio weight is Moore Capital Management at 0.1% of its book. 2 managers opened a new position this quarter: Point72 Asset Management LP, Holocene Advisors. 1 exited: Ancora Advisors.
10tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold CHE? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Moore Capital Management | Q2 2026 | 0.1% | $2.4m | 5,072 | -51% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.1% | $34.7m | 74,460 | – | new |
| Bridgewater Associates | Q2 2026 | 0.0% | $9.5m | 20,399 | 303% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $2.5m | 5,391 | 66% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $18.2m | 39,080 | 217% | added |
| Millennium Management | Q2 2026 | 0.0% | $23.5m | 50,404 | -52% | reduced |
| Holocene Advisors | Q2 2026 | 0.0% | $3.8m | 8,101 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $1.6m | 3,406 | -89% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.9m | 6,160 | -86% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $1.2m | 2,492 | -65% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Ancora Advisors | 0.0% | $21.5k |
How has hedge fund ownership of CHE changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $100.1m |
| Q1 2026 | 10 | $125.0m |
| Q4 2025 | 6 | $18.2m |
| Q3 2025 | 6 | $32.3m |
| Q2 2025 | 6 | $52.8m |
| Q1 2025 | 7 | $157.6m |
| Q4 2024 | 6 | $91.9m |
| Q3 2024 | 5 | $70.2m |
| Q2 2024 | 6 | $361.1m |
| Q1 2024 | 7 | $430.3m |
| Q4 2023 | 6 | $366.5m |
| Q3 2023 | 6 | $310.6m |
| Q2 2023 | 5 | $314.4m |
| Q1 2023 | 7 | $235.6m |
| Q4 2022 | 5 | $192.6m |
| Q3 2022 | 3 | $72.1m |
Counts every tracked manager that disclosed CHE in that quarter's filing, including managers that have since stopped filing.